BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15818431)

  • 1. Invasive fungal infection in children with persistent febrile neutropenia.
    Lai HP; Chen YC; Chang LY; Lu CY; Lee CY; Lin KH; Huang LM
    J Formos Med Assoc; 2005 Mar; 104(3):174-9. PubMed ID: 15818431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteremia during neutropenia is a predictive factor for invasive fungal infection in children.
    Sano H; Kobayashi R; Suzuki D; Kishimoto K; Yasuda K; Kobayashi K
    Pediatr Int; 2013 Apr; 55(2):145-50. PubMed ID: 23253211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Predictors of Invasive Fungal Infections in Children with Persistent Febrile Neutropenia Treated for Acute Leukemia - A Prospective Study.
    Kumar J; Singh A; Seth R; Xess I; Jana M; Kabra SK
    Indian J Pediatr; 2018 Dec; 85(12):1090-1095. PubMed ID: 29956075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Invasive fungal infections in children with cancer, neutropenia and fever, in Chile].
    Lucero Y; Brücher R; Alvarez AM; Becker A; Cofré J; Enríquez N; Payá E; Salgado C; Santolaya ME; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; O'Ryan M
    Rev Med Chil; 2002 Oct; 130(10):1139-46. PubMed ID: 12491831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive fungal infections in children with hematologic and malignant diseases.
    Ozsevik SN; Sensoy G; Karli A; Albayrak C; Dagdemir A; Belet N; Elli M; Fisgin T; Ozyurek E; Duru F; Albayrak D
    J Pediatr Hematol Oncol; 2015 Mar; 37(2):e69-72. PubMed ID: 25072372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empirical antifungal therapy in selected patients with persistent febrile neutropenia.
    Aguilar-Guisado M; Espigado I; Cordero E; Noguer M; Parody R; Pachón J; Cisneros JM
    Bone Marrow Transplant; 2010 Jan; 45(1):159-64. PubMed ID: 19525983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proven and probable invasive fungal infections in children with acute lymphoblastic leukaemia: results from an university hospital, 2005-2013.
    Sahbudak Bal Z; Yilmaz Karapinar D; Karadas N; Sen S; Onder Sivis Z; Akinci AB; Balkan C; Kavakli K; Vardar F; Aydinok Y
    Mycoses; 2015 Apr; 58(4):225-32. PubMed ID: 25728069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized study of empirical antifungal therapy for the treatment of chemotherapy-induced febrile neutropenia in children.
    Caselli D; Cesaro S; Ziino O; Ragusa P; Pontillo A; Pegoraro A; Santoro N; Zanazzo G; Poggi V; Giacchino M; Livadiotti S; Melchionda F; Chiodi M; Aricò M
    Br J Haematol; 2012 Jul; 158(2):249-255. PubMed ID: 22571507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients.
    Bodro M; Sabé N; Gomila A; Ayats J; Baliellas C; Roca J; Melilli E; Carratalà J
    Transplant Proc; 2012 Nov; 44(9):2682-5. PubMed ID: 23146493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.
    Segal BH; Almyroudis NG; Battiwalla M; Herbrecht R; Perfect JR; Walsh TJ; Wingard JR
    Clin Infect Dis; 2007 Feb; 44(3):402-9. PubMed ID: 17205448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients.
    El-Mahallawy HA; Shaker HH; Ali Helmy H; Mostafa T; Razak Abo-Sedah A
    Med Mycol; 2006 Dec; 44(8):733-9. PubMed ID: 17127630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
    Cordonnier C; Pautas C; Maury S; Vekhoff A; Farhat H; Suarez F; Dhédin N; Isnard F; Ades L; Kuhnowski F; Foulet F; Kuentz M; Maison P; Bretagne S; Schwarzinger M
    Clin Infect Dis; 2009 Apr; 48(8):1042-51. PubMed ID: 19281327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia.
    Przepiorka D; Buadi FK; McClune B
    Pharmacotherapy; 2008 Jan; 28(1):58-63. PubMed ID: 18154475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multicenter Study of Invasive Fungal Infections in Patients with Childhood-onset Systemic Lupus Erythematosus.
    Silva MF; Ferriani MP; Terreri MT; Pereira RM; Magalhães CS; Bonfá E; Campos LM; Okuda EM; Appenzeller S; Ferriani VP; Barbosa CM; Ramos VC; Lotufo S; Silva CA
    J Rheumatol; 2015 Dec; 42(12):2296-303. PubMed ID: 26568586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for breakthrough invasive fungal infection during secondary prophylaxis.
    Cornely OA; Böhme A; Reichert D; Reuter S; Maschmeyer G; Maertens J; Buchheidt D; Paluszewska M; Arenz D; Bethe U; Effelsberg J; Lövenich H; Sieniawski M; Haas A; Einsele H; Eimermacher H; Martino R; Silling G; Hahn M; Wacker S; Ullmann AJ; Karthaus M;
    J Antimicrob Chemother; 2008 Apr; 61(4):939-46. PubMed ID: 18272515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal antifungal therapy is not needed in persistent febrile neutropenia: a tailored diagnostic and therapeutic approach.
    Aguilar-Guisado M; Martín-Peña A; Espigado I; Ruiz Pérez de Pipaon M; Falantes J; de la Cruz F; Cisneros JM
    Haematologica; 2012 Mar; 97(3):464-71. PubMed ID: 22058202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
    Kubiak DW; Bryar JM; McDonnell AM; Delgado-Flores JO; Mui E; Baden LR; Marty FM
    Clin Ther; 2010 Apr; 32(4):637-48. PubMed ID: 20435233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
    Hamidah A; Lim YS; Zulkifli SZ; Zarina AL; Nordiah AJ; Jamal R
    Singapore Med J; 2007 Jul; 48(7):615-9. PubMed ID: 17609821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years.
    Hovi L; Saarinen-Pihkala UM; Vettenranta K; Saxen H
    Bone Marrow Transplant; 2000 Nov; 26(9):999-1004. PubMed ID: 11100280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.